NC
ABBV icon

NovaPoint Capital’s AbbVie ABBV Stock Holding History

NovaPoint Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16,522
Closed -$1.62M – 102
2020
Q2 		$1.62M Buy
16,522
+815
+5% +$71.8K 1.21% 32
2020
Q1 		$1.2M Buy
15,707
+125
+0.8% +$10.6K 1.09% 38
2019
Q4 		$1.38M Buy
+15,582
New +$1.29M 1.08% 47

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

NovaPoint Capital's ABBV Position: Q3 2020 in Review

NovaPoint Capital sold out of AbbVie (ABBV) in Q3 2020, closing a stake of 16,522 shares — an estimated $1.62M sold.

NovaPoint Capital first reported a position in ABBV in Q4 2019 and held it in 3 quarters. The position peaked at $1.62M in Q2 2020. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • NovaPoint Capital reported no remaining AbbVie position as of Q3 2020 after selling out during the quarter.
  • NovaPoint Capital sold 16,522 AbbVie shares in Q3 2020, an estimated $1.62M.
  • NovaPoint Capital first reported a position in AbbVie in Q4 2019 and held it in 3 quarters.
  • NovaPoint Capital's AbbVie position peaked at $1.62M in Q2 2020.
  • 2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on NovaPoint Capital's 13F filing for Q3 2020, filed 27 Oct 2020.